Re-Thinking Clinical Trials in Oncology
 Assessing the landscape of novel trial design for cancer therapies to improve data collection, enhance patient access, and drive clinical outcomes for breakthrough therapies

October 28, 2020 | Live Virtual Forum (EST)
View Program
Vendor Registration

Kenneth G. Faulkner PhD

Vice President of eCOA Scientific Services ERT

WEDNESDAY, OCTOBER 28

1:15 PM Designing Trials in the Age of Rapidly Developing Innovation

We have adaptive design, but what else can be considered in diverse approaches to treat cancer? What have we learned about what else might be considered to augment with real world evidence and other data sets that could be valuable to understand the safety and effectiveness of a new molecule? How can industry be “better” at designing trials to utilize resources in the best way possible? 

In Partnership With :

IQPC Corporate

QUESTIONS?
Contact us: 1-800-882-8684
Email: enquiry@iqpc.com

Iqpc Icon

©2024 IQPC. All rights reserved.